{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:49:56Z","timestamp":1767340196454,"version":"3.37.3"},"reference-count":277,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2022JJ40667"],"award-info":[{"award-number":["2022JJ40667"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Changsha","award":["kq2202128"],"award-info":[{"award-number":["kq2202128"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11064-024-04311-9","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T14:15:13Z","timestamp":1734185713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases"],"prefix":"10.1007","volume":"50","author":[{"given":"Mengying","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binish","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyue","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"4","key":"4311_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14499","volume":"30","author":"F Xiao","year":"2024","unstructured":"Xiao F, He Z, Wang S et al (2024) Regulatory mechanism of circular RNAs in neurodegenerative diseases. CNS Neurosci Ther 30(4):e14499. https:\/\/doi.org\/10.1111\/cns.14499","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"4311_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00204-023-03505-4","volume":"97","author":"C Guo","year":"2023","unstructured":"Guo C, Chen L, Wang Y (2023) Substance abuse and neurodegenerative diseases: focus on ferroptosis. Arch Toxicol 97(6):1519\u20131528. https:\/\/doi.org\/10.1007\/s00204-023-03505-4","journal-title":"Arch Toxicol"},{"issue":"7","key":"4311_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14155","volume":"46","author":"R Li","year":"2022","unstructured":"Li R, Robinson M, Ding X et al (2022) Genistein: a focus on several neurodegenerative diseases. J Food Biochem 46(7):e14155. https:\/\/doi.org\/10.1111\/jfbc.14155","journal-title":"J Food Biochem"},{"key":"4311_CR4","doi-asserted-by":"publisher","DOI":"10.1042\/NS20200008","author":"R Seager","year":"2020","unstructured":"Seager R, Lee L, Henley JM, Wilkinson KA (2020) Mechanisms and roles of mitochondrial localisation and dynamics in neuronal function. Neuronal Signal. https:\/\/doi.org\/10.1042\/NS20200008","journal-title":"Neuronal Signal"},{"key":"4311_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.10.022","author":"D Ben-Shachar","year":"2017","unstructured":"Ben-Shachar D (2017) Mitochondrial multifaceted dysfunction in schizophrenia: complex i as a possible pathological target. Schizophr Res. https:\/\/doi.org\/10.1016\/j.schres.2016.10.022","journal-title":"Schizophr Res"},{"key":"4311_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113114","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Park JH, Hayakawa K (2020) Therapeutic use of extracellular mitochondria in CNS injury and disease. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113114","journal-title":"Exp Neurol"},{"key":"4311_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1094356","author":"GC Walters","year":"2023","unstructured":"Walters GC, Usachev YM (2023) Mitochondrial calcium cycling in neuronal function and neurodegeneration. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1094356","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"4311_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrg1606","volume":"6","author":"RW Taylor","year":"2005","unstructured":"Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6(5):389\u2013402. https:\/\/doi.org\/10.1038\/nrg1606","journal-title":"Nat Rev Genet"},{"key":"4311_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0590-0","author":"X Sun","year":"2018","unstructured":"Sun X, Vaghjiani V, Jayasekara WSN, Cain JE, John JCS (2018) The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma. Clin Epigenet. https:\/\/doi.org\/10.1186\/s13148-018-0590-0","journal-title":"Clin Epigenet"},{"issue":"6","key":"4311_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11912-005-0013-1","volume":"7","author":"JL Velasquez","year":"2005","unstructured":"Velasquez JL, Lipkin SM (2005) What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer? Curr Oncol Rep 7(6):475\u2013479. https:\/\/doi.org\/10.1007\/s11912-005-0013-1","journal-title":"Curr Oncol Rep"},{"key":"4311_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394287-6.00004-5","author":"RM Donev","year":"2012","unstructured":"Donev RM, Howell OW (2012) Polymorphisms in neuropsychiatric and neuroinflammatory disorders and the role of next generation sequencing in early diagnosis and treatment. Adv Protein Chem Struct Biol. https:\/\/doi.org\/10.1016\/B978-0-12-394287-6.00004-5","journal-title":"Adv Protein Chem Struct Biol"},{"key":"4311_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.626066","author":"C Strafella","year":"2021","unstructured":"Strafella C, Caputo V, Termine A et al (2021) Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.626066","journal-title":"Front Neurol"},{"issue":"R1","key":"4311_CR13","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1093\/hmg\/ddae025","volume":"33","author":"LS Kremer","year":"2024","unstructured":"Kremer LS, Rehling P (2024) Coordinating mitochondrial translation with assembly of the OXPHOS complexes. Hum Mol Genet 33(R1):R47\u2013R52. https:\/\/doi.org\/10.1093\/hmg\/ddae025","journal-title":"Hum Mol Genet"},{"key":"4311_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/genes11040408","author":"B Peter","year":"2020","unstructured":"Peter B, Falkenberg M (2020) TWINKLE and other human mitochondrial DNA helicases: structure, function and disease. Genes (Basel). https:\/\/doi.org\/10.3390\/genes11040408","journal-title":"Genes (Basel)"},{"issue":"5","key":"4311_CR15","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s12035-020-02248-y","volume":"58","author":"M Song","year":"2021","unstructured":"Song M, Zhao X, Song F (2021) Aging-dependent mitophagy dysfunction in Alzheimer\u2019s disease. Mol Neurobiol 58(5):2362\u20132378. https:\/\/doi.org\/10.1007\/s12035-020-02248-y","journal-title":"Mol Neurobiol"},{"key":"4311_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2023.05.007","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis\u2014an updated review. Mitochondrion. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","journal-title":"Mitochondrion"},{"issue":"9","key":"4311_CR17","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1007\/s12035-015-9515-5","volume":"53","author":"C Cadonic","year":"2016","unstructured":"Cadonic C, Sabbir MG, Albensi BC (2016) Mechanisms of mitochondrial dysfunction in Alzheimer\u2019s disease. Mol Neurobiol 53(9):6078\u20136090. https:\/\/doi.org\/10.1007\/s12035-015-9515-5","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4311_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, Xia X, Wang Y, Zheng JC (2022) Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease. J Neuroinflammation 19(1):248. https:\/\/doi.org\/10.1186\/s12974-022-02613-9","journal-title":"J Neuroinflammation"},{"issue":"6","key":"4311_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1134\/S0006297921060055","volume":"86","author":"VS Sukhorukov","year":"2021","unstructured":"Sukhorukov VS, Mudzhiri NM, Voronkova AS, Baranich TI, Glinkina VV, Illarioshkin SN (2021) Mitochondrial disorders in Alzheimer\u2019s disease. Biochemistry (Mosc) 86(6):667\u2013679. https:\/\/doi.org\/10.1134\/S0006297921060055","journal-title":"Biochemistry (Mosc)"},{"issue":"3","key":"4311_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr JS, Adriaanse BA, Greig NH et al (2017) Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms. Trends Neurosci 40(3):151\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2017.01.002","journal-title":"Trends Neurosci"},{"issue":"15","key":"4311_CR21","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1073\/pnas.92.15.6892","volume":"92","author":"T Hutchin","year":"1995","unstructured":"Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92(15):6892\u20136895. https:\/\/doi.org\/10.1073\/pnas.92.15.6892","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"4311_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.neurobiolaging.2010.04.031","volume":"31","author":"A Lakatos","year":"2010","unstructured":"Lakatos A, Derbeneva O, Younes D et al (2010) Association between mitochondrial DNA variations and Alzheimer\u2019s disease in the ADNI cohort. Neurobiol Aging 31(8):1355\u20131363. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.031","journal-title":"Neurobiol Aging"},{"issue":"2","key":"4311_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/elps.200500420","volume":"27","author":"NS Hamblet","year":"2006","unstructured":"Hamblet NS, Ragland B, Ali M, Conyers B, Castora FJ (2006) Mutations in mitochondrial-encoded cytochrome c oxidase subunits i, II, and III genes detected in Alzheimer\u2019s disease using single-strand conformation polymorphism. Electrophoresis 27(2):398\u2013408. https:\/\/doi.org\/10.1002\/elps.200500420","journal-title":"Electrophoresis"},{"key":"4311_CR24","first-page":"2155","volume":"29","author":"C Liangmei","year":"2016","unstructured":"Liangmei C, Ying C, Feihu L et al (2016) Relationship between Alzheimer\u2019s disease and mitochondria coenzyme II gene. Pak J Pharm Sci 29:2155\u20132158","journal-title":"Pak J Pharm Sci"},{"issue":"Suppl","key":"4311_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1601-183X.2006.00225.x","volume":"5","author":"M Grazina","year":"2006","unstructured":"Grazina M, Pratas J, Silva F, Oliveira S, Santana I, Oliveira C (2006) Genetic basis of Alzheimer\u2019s dementia: role of mtDNA mutations. Genes Brain Behav 5(Suppl):292. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00225.x","journal-title":"Genes Brain Behav"},{"issue":"4","key":"4311_CR26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41380-022-01769-3","volume":"28","author":"B Miller","year":"2023","unstructured":"Miller B, Kim SJ, Mehta HH et al (2023) Mitochondrial DNA variation in Alzheimer\u2019s disease reveals a unique microprotein called SHMOOSE. Mol Psychiatry 28(4):1813\u20131826. https:\/\/doi.org\/10.1038\/s41380-022-01769-3","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4311_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JAD-2011-110710","volume":"27","author":"A Maruszak","year":"2011","unstructured":"Maruszak A, Safranow K, Branicki W et al (2011) The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer\u2019s disease risk. J Alzheimers Dis 27(1):197\u2013210. https:\/\/doi.org\/10.3233\/JAD-2011-110710","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"4311_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/biomedicines10081782","volume":"10","author":"X Xu","year":"2022","unstructured":"Xu X, Wang H, Bennett DA, Zhang Q, Wang G, Zhang H (2022) Systems genetic identification of mitochondrion-associated Alzheimer\u2019s disease genes and implications for disease risk prediction. Biomedicines 10(8):20. https:\/\/doi.org\/10.3390\/biomedicines10081782","journal-title":"Biomedicines"},{"issue":"3","key":"4311_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbrc.2007.07.055","volume":"361","author":"M Asari","year":"2007","unstructured":"Asari M, Tan Y, Watanabe S, Shimizu K, Shiono H (2007) Effect of length variations at nucleotide positions 303\u2013315 in human mitochondrial DNA on transcription termination. Biochem Biophys Res Commun 361(3):641\u2013644. https:\/\/doi.org\/10.1016\/j.bbrc.2007.07.055","journal-title":"Biochem Biophys Res Commun"},{"issue":"29","key":"4311_CR30","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1073\/pnas.0403649101","volume":"101","author":"PE Coskun","year":"2004","unstructured":"Coskun PE, Beal MF, Wallace DC (2004) Alzheimer\u2019s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101(29):10726\u201310731. https:\/\/doi.org\/10.1073\/pnas.0403649101","journal-title":"Proc Natl Acad Sci USA"},{"key":"4311_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.02.015","author":"H Wu","year":"2018","unstructured":"Wu H, Li T, Wang Z et al (2018) Mitochondrial DNA variants modulate genetic susceptibility to Parkinson\u2019s disease in Han Chinese. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2018.02.015","journal-title":"Neurobiol Dis"},{"issue":"4","key":"4311_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/19401736.2013.878902","volume":"26","author":"K Mousavizadeh","year":"2015","unstructured":"Mousavizadeh K, Rajabi P, Alaee M, Dadgar S, Houshmand M (2015) Usage of mitochondrial d-loop variation to predict risk for Huntington disease. Mitochondrial DNA 26(4):579\u2013582. https:\/\/doi.org\/10.3109\/19401736.2013.878902","journal-title":"Mitochondrial DNA"},{"issue":"1","key":"4311_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.patbio.2013.07.013","volume":"62","author":"M Maalej","year":"2014","unstructured":"Maalej M, Mkaouar-Rebai E, Mnif M et al (2014) A mitochondrial implication in a Tunisian patient with Friedreich\u2019s ataxia-like. Pathol Biol (Paris) 62(1):41\u201348. https:\/\/doi.org\/10.1016\/j.patbio.2013.07.013","journal-title":"Pathol Biol (Paris)"},{"issue":"2","key":"4311_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mito.2006.01.005","volume":"6","author":"M Houshmand","year":"2006","unstructured":"Houshmand M, Panahi MSS, Nafisi S, Soltanzadeh A, Alkandari FM (2006) Identification and sizing of GAA trinucleotide repeat expansion, investigation for d-loop variations and mitochondrial deletions in Iranian patients with Friedreich\u2019s ataxia. Mitochondrion 6(2):82\u201388. https:\/\/doi.org\/10.1016\/j.mito.2006.01.005","journal-title":"Mitochondrion"},{"issue":"1","key":"4311_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/geno.1993.1299","volume":"17","author":"JM Shoffner","year":"1993","unstructured":"Shoffner JM, Brown MD, Torroni A et al (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17(1):171\u2013184. https:\/\/doi.org\/10.1006\/geno.1993.1299","journal-title":"Genomics"},{"issue":"1 Suppl","key":"4311_CR36","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/s0197-4580(98)00028-1","volume":"19","author":"Y Tanno","year":"1998","unstructured":"Tanno Y, Okuizumi K, Tsuji S (1998) MtDNA polymorphisms in Japanese sporadic Alzheimer\u2019s disease. Neurobiol Aging 19(1 Suppl):S47\u2013S51. https:\/\/doi.org\/10.1016\/s0197-4580(98)00028-1","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4311_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K","volume":"85","author":"P Chagnon","year":"1999","unstructured":"Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, Gauvreau D (1999) Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French\u2013Canadian founder population. Am J Med Genet 85(1):20\u201330","journal-title":"Am J Med Genet"},{"issue":"3","key":"4311_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P","volume":"61","author":"MD Brown","year":"1996","unstructured":"Brown MD, Shoffner JM, Kim YL et al (1996) Mitochondrial DNA sequence analysis of four Alzheimer\u2019s and Parkinson\u2019s disease patients. Am J Med Genet 61(3):283\u2013289","journal-title":"Am J Med Genet"},{"issue":"3","key":"4311_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000085555","volume":"53","author":"M Grazina","year":"2005","unstructured":"Grazina M, Silva F, Santana I et al (2005) Mitochondrial DNA variants in a Portuguese population of patients with Alzheimer\u2019s disease. Eur Neurol 53(3):121\u2013124. https:\/\/doi.org\/10.1159\/000085555","journal-title":"Eur Neurol"},{"issue":"2","key":"4311_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41380-023-02344-0","volume":"29","author":"SJ Kim","year":"2024","unstructured":"Kim SJ, Miller B, Hartel NG et al (2024) A naturally occurring variant of SHLP2 is a protective factor in Parkinson\u2019s disease. Mol Psychiatry 29(2):505\u2013517. https:\/\/doi.org\/10.1038\/s41380-023-02344-0","journal-title":"Mol Psychiatry"},{"issue":"11","key":"4311_CR41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00702-008-0121-9","volume":"115","author":"K Gaweda-Walerych","year":"2008","unstructured":"Gaweda-Walerych K, Maruszak A, Safranow K et al (2008) Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson\u2019s disease risk in a polish PD cohort. J Neural Transm (Vienna) 115(11):1521\u20131526. https:\/\/doi.org\/10.1007\/s00702-008-0121-9","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"4311_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0531-5565(02)00266-8","volume":"38","author":"OA Ross","year":"2003","unstructured":"Ross OA, Mccormack R, Maxwell LD et al (2003) Mt4216c variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson\u2019s disease in the Irish. Exp Gerontol 38(4):397\u2013405. https:\/\/doi.org\/10.1016\/s0531-5565(02)00266-8","journal-title":"Exp Gerontol"},{"issue":"1\u20132","key":"4311_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000170885","volume":"6","author":"S Safaei","year":"2009","unstructured":"Safaei S, Houshmand M, Banoei MM et al (2009) Mitochondrial tRNALeu\/lys and ATPase 6\/8 gene variations in spinocerebellar ataxias. Neurodegener Dis 6(1\u20132):16\u201322. https:\/\/doi.org\/10.1159\/000170885","journal-title":"Neurodegener Dis"},{"issue":"2","key":"4311_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10571-008-9315-9","volume":"29","author":"MM Heidari","year":"2009","unstructured":"Heidari MM, Houshmand M, Hosseinkhani S, Nafissi S, Scheiber-Mojdehkar B, Khatami M (2009) A novel mitochondrial heteroplasmic c13806a point mutation associated with Iranian Friedreich\u2019s ataxia. Cell Mol Neurobiol 29(2):225\u2013233. https:\/\/doi.org\/10.1007\/s10571-008-9315-9","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"4311_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.compbiolchem.2008.03.014","volume":"32","author":"S Takasaki","year":"2008","unstructured":"Takasaki S (2008) Mitochondrial SNPs associated with Japanese centenarians, Alzheimer\u2019s patients, and Parkinson\u2019s patients. Comput Biol Chem 32(5):332\u2013337. https:\/\/doi.org\/10.1016\/j.compbiolchem.2008.03.014","journal-title":"Comput Biol Chem"},{"issue":"2","key":"4311_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/geno.1994.1525","volume":"23","author":"M Corral-Debrinski","year":"1994","unstructured":"Corral-Debrinski M, Horton T, Lott MT et al (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23(2):471\u2013476. https:\/\/doi.org\/10.1006\/geno.1994.1525","journal-title":"Genomics"},{"issue":"2","key":"4311_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-0404.1995.tb00423.x","volume":"91","author":"DE Shan","year":"1995","unstructured":"Shan DE, Yeh SI, Wan YC, Wei YH (1995) Absence of 4,977-bp deletion of blood cell mitochondrial DNA in patients with young-onset Parkinson\u2019s disease. Acta Neurol Scand 91(2):149\u2013152. https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb00423.x","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"4311_CR48","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1097\/00001756-200008030-00032","volume":"11","author":"GK Dhaliwal","year":"2000","unstructured":"Dhaliwal GK, Grewal RP (2000) Mitochondrial DNA deletion mutation levels are elevated in ALS brains. NeuroReport 11(11):2507\u20132509. https:\/\/doi.org\/10.1097\/00001756-200008030-00032","journal-title":"NeuroReport"},{"issue":"6","key":"4311_CR49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mus.10504","volume":"28","author":"LS Ro","year":"2003","unstructured":"Ro LS, Lai SL, Chen CM, Chen ST (2003) Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study. Muscle Nerve 28(6):737\u2013743. https:\/\/doi.org\/10.1002\/mus.10504","journal-title":"Muscle Nerve"},{"issue":"3","key":"4311_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000117233","volume":"36","author":"B Janetzky","year":"1996","unstructured":"Janetzky B, Schmid C, Bischof F et al (1996) Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases. Eur Neurol 36(3):149\u2013153. https:\/\/doi.org\/10.1159\/000117233","journal-title":"Eur Neurol"},{"issue":"2","key":"4311_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/(SICI)1097-4547(19960415)44:2<174::AID-JNR10>3.0.CO;2-6","volume":"44","author":"S Kosel","year":"1996","unstructured":"Kosel S, Lucking CB, Egensperger R, Mehraein P, Graeber MB (1996) Mitochondrial NADH dehydrogenase and CYP2d6 genotypes in lewy-body Parkinsonism. J Neurosci Res 44(2):174\u2013183","journal-title":"J Neurosci Res"},{"key":"4311_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2022.06.008","author":"V Castaneda","year":"2022","unstructured":"Castaneda V, Haro-Vinueza A, Salinas I, Caicedo A, Mendez MA (2022) The MitoAging project: single nucleotide polymorphisms (SNPs) in mitochondrial genes and their association to longevity. Mitochondrion. https:\/\/doi.org\/10.1016\/j.mito.2022.06.008","journal-title":"Mitochondrion"},{"key":"4311_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2014.12.005","author":"AM Gusdon","year":"2015","unstructured":"Gusdon AM, Fang F, Chen J et al (2015) Association of the mt-ND2 5178a\/c polymorphism with Parkinson\u2019s disease. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2014.12.005","journal-title":"Neurosci Lett"},{"issue":"4","key":"4311_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10038-008-0259-1","volume":"53","author":"H Latsoudis","year":"2008","unstructured":"Latsoudis H, Spanaki C, Chlouverakis G, Plaitakis A (2008) Mitochondrial DNA polymorphisms and haplogroups in Parkinson\u2019s disease and control individuals with a similar genetic background. J Hum Genet 53(4):349\u2013356. https:\/\/doi.org\/10.1007\/s10038-008-0259-1","journal-title":"J Hum Genet"},{"issue":"1","key":"4311_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3233\/JAD-2010-100123","volume":"21","author":"J Lu","year":"2010","unstructured":"Lu J, Wang K, Rodova M et al (2010) Polymorphic variation in cytochrome oxidase subunit genes. J Alzheimers Dis 21(1):141\u2013154. https:\/\/doi.org\/10.3233\/JAD-2010-100123","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4311_CR56","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1212\/wnl.54.3.703","volume":"54","author":"DK Simon","year":"2000","unstructured":"Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR (2000) Mitochondrial DNA mutations in complex i and tRNA genes in Parkinson\u2019s disease. Neurology 54(3):703\u2013709. https:\/\/doi.org\/10.1212\/wnl.54.3.703","journal-title":"Neurology"},{"key":"4311_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/794530","author":"V Loera-Castaneda","year":"2014","unstructured":"Loera-Castaneda V, Sandoval-Ramirez L, Pacheco MF et al (2014) Novel point mutations and a8027g polymorphism in mitochondrial-DNA-encoded cytochrome c oxidase II gene in Mexican patients with probable Alzheimer disease. Int J Alzheimers Dis. https:\/\/doi.org\/10.1155\/2014\/794530","journal-title":"Int J Alzheimers Dis"},{"issue":"1\u20132","key":"4311_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0006-8993(00)03190-5","volume":"893","author":"X Qiu","year":"2001","unstructured":"Qiu X, Chen Y, Zhou M (2001) Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer\u2019s disease. Brain Res 893(1\u20132):261\u2013263. https:\/\/doi.org\/10.1016\/s0006-8993(00)03190-5","journal-title":"Brain Res"},{"issue":"8","key":"4311_CR59","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/ene.13020","volume":"23","author":"CW Liou","year":"2016","unstructured":"Liou CW, Chuang JH, Chen JB et al (2016) Mitochondrial DNA variants as genetic risk factors for Parkinson disease. Eur J Neurol 23(8):1289\u20131300. https:\/\/doi.org\/10.1111\/ene.13020","journal-title":"Eur J Neurol"},{"issue":"7","key":"4311_CR60","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10571-008-9261-6","volume":"28","author":"S Kasraie","year":"2008","unstructured":"Kasraie S, Houshmand M, Banoei MM et al (2008) Investigation of tRNALeu\/lys and ATPase 6 genes mutations in Huntington\u2019s disease. Cell Mol Neurobiol 28(7):933\u2013938. https:\/\/doi.org\/10.1007\/s10571-008-9261-6","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"4311_CR61","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s13760-020-01490-4","volume":"121","author":"M Maalej","year":"2021","unstructured":"Maalej M, Kammoun F, Kharrat M et al (2021) A first description of ataxia with vitamin e deficiency associated with MT-TG gene mutation. Acta Neurol Belg 121(6):1733\u20131740. https:\/\/doi.org\/10.1007\/s13760-020-01490-4","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"4311_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cns.12972","volume":"25","author":"HL Dong","year":"2019","unstructured":"Dong HL, Ma Y, Li QF et al (2019) Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing. CNS Neurosci Ther 25(1):21\u201329. https:\/\/doi.org\/10.1111\/cns.12972","journal-title":"CNS Neurosci Ther"},{"issue":"1\u20132","key":"4311_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jns.2007.01.005","volume":"254","author":"YC Lee","year":"2007","unstructured":"Lee YC, Lu YC, Chang MH, Soong BW (2007) Common mitochondrial DNA and POLG1 mutations are rare in the Chinese patients with adult-onset ataxia on Taiwan. J Neurol Sci 254(1\u20132):65\u201368. https:\/\/doi.org\/10.1016\/j.jns.2007.01.005","journal-title":"J Neurol Sci"},{"issue":"12","key":"4311_CR64","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/jmg.2007.052902","volume":"44","author":"K Craig","year":"2007","unstructured":"Craig K, Elliott HR, Keers SM et al (2007) Episodic ataxia and hemiplegia caused by the 8993t->c mitochondrial DNA mutation. J Med Genet 44(12):797\u2013799. https:\/\/doi.org\/10.1136\/jmg.2007.052902","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"4311_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2005.04.016","volume":"236","author":"C Huerta","year":"2005","unstructured":"Huerta C, Castro MG, Coto E et al (2005) Mitochondrial DNA polymorphisms and risk of Parkinson\u2019s disease in Spanish population. J Neurol Sci 236(1\u20132):49\u201354. https:\/\/doi.org\/10.1016\/j.jns.2005.04.016","journal-title":"J Neurol Sci"},{"key":"4311_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/srep17170","author":"Q Chu","year":"2015","unstructured":"Chu Q, Luo X, Zhan X, Ren Y, Pang H (2015) Female genetic distribution bias in mitochondrial genome observed in Parkinson\u2019s disease patients in northern china. Sci Rep. https:\/\/doi.org\/10.1038\/srep17170","journal-title":"Sci Rep"},{"issue":"44","key":"4311_CR67","doi-asserted-by":"publisher","first-page":"78023","DOI":"10.18632\/oncotarget.20920","volume":"8","author":"F Hua","year":"2017","unstructured":"Hua F, Zhang X, Hou B, Xue L, Xie A (2017) Relationship between mitochondrial DNA a10398g polymorphism and Parkinson\u2019s disease: a meta-analysis. Oncotarget 8(44):78023\u201378030. https:\/\/doi.org\/10.18632\/oncotarget.20920","journal-title":"Oncotarget"},{"issue":"3","key":"4311_CR68","first-page":"219","volume":"14","author":"MM Heidari","year":"2011","unstructured":"Heidari MM, Khatami M (2011) Novel missense mitochondrial ND4l gene mutations in Friedreich\u2019s ataxia. Iran J Basic Med Sci 14(3):219\u2013224","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"4311_CR69","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1212\/wnl.53.8.1787","volume":"53","author":"DK Simon","year":"1999","unstructured":"Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR (1999) Familial multisystem degeneration with Parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53(8):1787\u20131793. https:\/\/doi.org\/10.1212\/wnl.53.8.1787","journal-title":"Neurology"},{"issue":"9","key":"4311_CR70","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jmg.2008.058628","volume":"45","author":"C Piccoli","year":"2008","unstructured":"Piccoli C, Ripoli M, Quarato G et al (2008) Coexistence of mutations in PINK1 and mitochondrial DNA in early onset Parkinsonism. J Med Genet 45(9):596\u2013602. https:\/\/doi.org\/10.1136\/jmg.2008.058628","journal-title":"J Med Genet"},{"issue":"22","key":"4311_CR71","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1212\/WNL.0b013e318294b434","volume":"80","author":"G Hudson","year":"2013","unstructured":"Hudson G, Nalls M, Evans JR et al (2013) Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology 80(22):2042\u20132048. https:\/\/doi.org\/10.1212\/WNL.0b013e318294b434","journal-title":"Neurology"},{"issue":"3","key":"4311_CR72","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11033-021-06978-7","volume":"49","author":"SN Ben","year":"2022","unstructured":"Ben SN, Boussetta S, de Rojas I et al (2022) Mitochondrial DNA and Alzheimer\u2019s disease: a first case-control study of the Tunisian population. Mol Biol Rep 49(3):1687\u20131700. https:\/\/doi.org\/10.1007\/s11033-021-06978-7","journal-title":"Mol Biol Rep"},{"issue":"4","key":"4311_CR73","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2990.1997.tb01301.x","volume":"23","author":"R Egensperger","year":"1997","unstructured":"Egensperger R, Kosel S, Schnopp NM, Mehraein P, Graeber MB (1997) Association of the mitochondrial tRNA(a4336g) mutation with Alzheimer\u2019s and Parkinson\u2019s diseases. Neuropathol Appl Neurobiol 23(4):315\u2013321","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2\u20133","key":"4311_CR74","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neulet.2004.08.012","volume":"370","author":"D Otaegui","year":"2004","unstructured":"Otaegui D, Paisan C, Saenz A et al (2004) Mitochondrial polymporphisms in Parkinson\u2019s disease. Neurosci Lett 370(2\u20133):171\u2013174. https:\/\/doi.org\/10.1016\/j.neulet.2004.08.012","journal-title":"Neurosci Lett"},{"issue":"8","key":"4311_CR75","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/0883073811431012","volume":"27","author":"JA Chevallier","year":"2012","unstructured":"Chevallier JA, Koenig MK (2012) Friedreich-like ataxia as an initial manifestation of mitochondrial DNA 8344a>g mutation. J Child Neurol 27(8):1056\u20131058. https:\/\/doi.org\/10.1177\/0883073811431012","journal-title":"J Child Neurol"},{"key":"4311_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2013.04.004","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"key":"4311_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.10.011","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic Parkinsonism. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2012.10.011","journal-title":"Neurobiol Dis"},{"issue":"4","key":"4311_CR78","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s11011-022-00931-8","volume":"37","author":"A Mohammadipour","year":"2022","unstructured":"Mohammadipour A (2022) A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson\u2019s disease. Metab Brain Dis 37(4):889\u2013900. https:\/\/doi.org\/10.1007\/s11011-022-00931-8","journal-title":"Metab Brain Dis"},{"key":"4311_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149246","author":"C Wu","year":"2024","unstructured":"Wu C, Yin H, Fu S, Yoo H, Zhang M, Park H (2024) Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington\u2019s disease. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149246","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"4311_CR80","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2174\/1389450122666210224105945","volume":"22","author":"A Sharma","year":"2021","unstructured":"Sharma A, Behl T, Sharma L, Aelya L, Bungau S (2021) Mitochondrial dysfunction in Huntington\u2019s disease: pathogenesis and therapeutic opportunities. Curr Drug Targets 22(14):1637\u20131667. https:\/\/doi.org\/10.2174\/1389450122666210224105945","journal-title":"Curr Drug Targets"},{"issue":"10","key":"4311_CR81","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/wnl.45.10.1879","volume":"45","author":"TM Horton","year":"1995","unstructured":"Horton TM, Graham BH, Corral-Debrinski M et al (1995) Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington\u2019s disease patients. Neurology 45(10):1879\u20131883. https:\/\/doi.org\/10.1212\/wnl.45.10.1879","journal-title":"Neurology"},{"key":"4311_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12030233","author":"N Candelise","year":"2022","unstructured":"Candelise N, Salvatori I, Scaricamazza S et al (2022) Mechanistic insights of mitochondrial dysfunction in amyotrophic lateral sclerosis: an update on a lasting relationship. Metabolites. https:\/\/doi.org\/10.3390\/metabo12030233","journal-title":"Metabolites"},{"issue":"4","key":"4311_CR83","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s13311-022-01262-3","volume":"19","author":"AT Nelson","year":"2022","unstructured":"Nelson AT, Trotti D (2022) Altered bioenergetics and metabolic homeostasis in amyotrophic lateral sclerosis. Neurotherapeutics 19(4):1102\u20131118. https:\/\/doi.org\/10.1007\/s13311-022-01262-3","journal-title":"Neurotherapeutics"},{"key":"4311_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2021.07.008","author":"S Edgar","year":"2021","unstructured":"Edgar S, Ellis M, Abdul-Aziz NA et al (2021) Mutation analysis of SOD1, c9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS). Neurobiol Aging. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.07.008","journal-title":"Neurobiol Aging"},{"key":"4311_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8217663","author":"J Peng","year":"2022","unstructured":"Peng J, Pan J, Mo J, Peng Y (2022) MPO\/HOCl facilitates apoptosis and ferroptosis in the SOD1(g93a) motor neuron of amyotrophic lateral sclerosis. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/8217663","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4311_CR86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","volume":"33","author":"T Wang","year":"2021","unstructured":"Wang T, Liu H, Itoh K et al (2021) C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex i assembly. Cell Metab 33(3):531\u2013546. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.005","journal-title":"Cell Metab"},{"issue":"32","key":"4311_CR87","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","volume":"30","author":"YF Xu","year":"2010","unstructured":"Xu YF, Gendron TF, Zhang YJ et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30(32):10851\u201310859. https:\/\/doi.org\/10.1523\/JNEUROSCI.1630-10.2010","journal-title":"J Neurosci"},{"key":"4311_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/genes14111981","author":"EC Genin","year":"2023","unstructured":"Genin EC, Abou-Ali M, Paquis-Flucklinger V (2023) Mitochondria, a key target in amyotrophic lateral sclerosis pathogenesis. Genes (Basel). https:\/\/doi.org\/10.3390\/genes14111981","journal-title":"Genes (Basel)"},{"issue":"4","key":"4311_CR89","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1046\/j.0022-3042.2001.00731.x","volume":"80","author":"FR Wiedemann","year":"2002","unstructured":"Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA (2002) Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem 80(4):616\u2013625. https:\/\/doi.org\/10.1046\/j.0022-3042.2001.00731.x","journal-title":"J Neurochem"},{"issue":"2","key":"4311_CR90","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00415-021-10659-7","volume":"269","author":"J Ni","year":"2022","unstructured":"Ni J, Liu Z, Yuan Y et al (2022) Mitochondrial genome variations are associated with amyotrophic lateral sclerosis in patients from mainland china. J Neurol 269(2):805\u2013814. https:\/\/doi.org\/10.1007\/s00415-021-10659-7","journal-title":"J Neurol"},{"issue":"12","key":"4311_CR91","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.freeradbiomed.2009.03.007","volume":"46","author":"A Navarro","year":"2009","unstructured":"Navarro A, Boveris A, Bandez MJ et al (2009) Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med 46(12):1574\u20131580. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.03.007","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"4311_CR92","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jnr.22011","volume":"87","author":"YC Yu","year":"2009","unstructured":"Yu YC, Kuo CL, Cheng WL, Liu CS, Hsieh M (2009) Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J Neurosci Res 87(8):1884\u20131891. https:\/\/doi.org\/10.1002\/jnr.22011","journal-title":"J Neurosci Res"},{"key":"4311_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00130","author":"A Martelli","year":"2014","unstructured":"Martelli A, Puccio H (2014) Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2014.00130","journal-title":"Front Pharmacol"},{"issue":"15","key":"4311_CR94","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/blood.2020006987","volume":"137","author":"F Petit","year":"2021","unstructured":"Petit F, Drecourt A, Dussiot M et al (2021) Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich ataxia fibroblasts. Blood 137(15):2090\u20132102. https:\/\/doi.org\/10.1182\/blood.2020006987","journal-title":"Blood"},{"key":"4311_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00682","author":"PF Chinnery","year":"2018","unstructured":"Chinnery PF, Gomez-Duran A (2018) Oldies but goldies mtDNA population variants and neurodegenerative diseases. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00682","journal-title":"Front Neurosci"},{"issue":"1","key":"4311_CR96","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12031-009-9297-1","volume":"41","author":"X Yang","year":"2010","unstructured":"Yang X, Dai G, Li G, Yang ES (2010) Coenzyme q10 reduces beta-amyloid plaque in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. J Mol Neurosci 41(1):110\u2013113. https:\/\/doi.org\/10.1007\/s12031-009-9297-1","journal-title":"J Mol Neurosci"},{"issue":"5","key":"4311_CR97","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s11064-020-02996-2","volume":"45","author":"GI Fouad","year":"2020","unstructured":"Fouad GI (2020) Combination of omega 3 and coenzyme q10 exerts neuroprotective potential against hypercholesterolemia\u2014induced Alzheimer\u2019s\u2014like disease in rats. Neurochem Res 45(5):1142\u20131155. https:\/\/doi.org\/10.1007\/s11064-020-02996-2","journal-title":"Neurochem Res"},{"key":"4311_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137346","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Ma P, Yang P et al (2023) Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson\u2019s disease. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2023.137346","journal-title":"Neurosci Lett"},{"key":"4311_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838173","author":"MR Du","year":"2022","unstructured":"Du MR, Gao QY, Liu CL, Bai LY, Li T, Wei FL (2022) Exploring the pharmacological potential of metformin for neurodegenerative diseases. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.838173","journal-title":"Front Aging Neurosci"},{"key":"4311_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2019.01.025","author":"H Komaki","year":"2019","unstructured":"Komaki H, Faraji N, Komaki A et al (2019) Investigation of protective effects of coenzyme q10 on impaired synaptic plasticity in a male rat model of Alzheimer\u2019s disease. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.01.025","journal-title":"Brain Res Bull"},{"issue":"4","key":"4311_CR101","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00213-023-06338-2","volume":"240","author":"M Asadbegi","year":"2023","unstructured":"Asadbegi M, Komaki H, Faraji N et al (2023) Effectiveness of coenzyme q10 on learning and memory and synaptic plasticity impairment in an aged a\u03b2-induced rat model of Alzheimer\u2019s disease: a behavioral, biochemical, and electrophysiological study. Psychopharmacology 240(4):951\u2013967. https:\/\/doi.org\/10.1007\/s00213-023-06338-2","journal-title":"Psychopharmacology"},{"key":"4311_CR102","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230096","author":"S Puoyan-Majd","year":"2024","unstructured":"Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A (2024) The protective effects of high-intensity interval training combined with q10 supplementation on learning and memory impairments in male rats with amyloid-\u03b2-induced Alzheimer\u2019s disease. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-230096","journal-title":"J Alzheimers Dis"},{"key":"4311_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.04.014","author":"L Li","year":"2017","unstructured":"Li L, Xu D, Lin J et al (2017) Coenzyme q10 attenuated \u03b2-amyloid 25\u201335-induced inflammatory responses in PC12 cells through regulation of the NF-\u03bab signaling pathway. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.04.014","journal-title":"Brain Res Bull"},{"issue":"1","key":"4311_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-2011-110209","volume":"27","author":"M Dumont","year":"2011","unstructured":"Dumont M, Kipiani K, Yu F et al (2011) Coenzyme q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 27(1):211\u2013223. https:\/\/doi.org\/10.3233\/JAD-2011-110209","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4311_CR105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1600-079X.2009.00692.x","volume":"47","author":"JM Olcese","year":"2009","unstructured":"Olcese JM, Cao C, Mori T et al (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47(1):82\u201396. https:\/\/doi.org\/10.1111\/j.1600-079X.2009.00692.x","journal-title":"J Pineal Res"},{"issue":"1","key":"4311_CR106","first-page":"39","volume":"21","author":"LI Brusco","year":"2000","unstructured":"Brusco LI, M\u00e1rquez M, Cardinali DP (2000) Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer\u2019s disease. Neuro Endocrinol Lett 21(1):39\u201342","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"4311_CR107","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/nrc.10079","volume":"33","author":"HW Xu","year":"2003","unstructured":"Xu HW, Fan XT, Gao EQ, Wu X, Cao J, Li HD (2003) Effect of melatonin on \u03b2-amyloid peptide overexpression and memory impairment in a rat AD-model and the influence of bicuculline. Neurosci Res Commun 33(1):44\u201352. https:\/\/doi.org\/10.1002\/nrc.10079","journal-title":"Neurosci Res Commun"},{"issue":"1","key":"4311_CR108","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-150161","volume":"47","author":"EA Rudnitskaya","year":"2015","unstructured":"Rudnitskaya EA, Muraleva NA, Maksimova KY, Kiseleva E, Kolosova NG, Stefanova NA (2015) Melatonin attenuates memory impairment, amyloid-\u03b2 accumulation, and neurodegeneration in a rat model of sporadic Alzheimer\u2019s disease. J Alzheimers Dis 47(1):103\u2013116. https:\/\/doi.org\/10.3233\/JAD-150161","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"4311_CR109","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1046\/j.1471-4159.2003.01997.x","volume":"86","author":"E Matsubara","year":"2003","unstructured":"Matsubara E, Bryant-Thomas T, Pacheco J et al (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer\u2019s disease. J Neurochem 86(5):1312. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01997.x","journal-title":"J Neurochem"},{"issue":"8","key":"4311_CR110","first-page":"3542","volume":"23","author":"C Wang","year":"2019","unstructured":"Wang C, Song C, Wang X et al (2019) Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer\u2019s disease. Eur Rev Med Pharmacol Sci 23(8):3542\u20133550","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4311_CR111","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12774","author":"C Chen","year":"2021","unstructured":"Chen C, Yang C, Wang J et al (2021) Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer\u2019s disease. J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12774","journal-title":"J Pineal Res"},{"key":"4311_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2023.01.005","author":"MK Andrade","year":"2023","unstructured":"Andrade MK, Souza LC, Azevedo EM et al (2023) Melatonin reduces \u03b2-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer\u2019s disease model. IBRO Neurosci Rep. https:\/\/doi.org\/10.1016\/j.ibneur.2023.01.005","journal-title":"IBRO Neurosci Rep"},{"issue":"4","key":"4311_CR113","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4103\/1673-5374.295349","volume":"16","author":"P Wang","year":"2021","unstructured":"Wang P, Sui H, Li X, Bai L, Bi J, Lai H (2021) Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer\u2019s disease. Neural Regen Res 16(4):757\u2013764. https:\/\/doi.org\/10.4103\/1673-5374.295349","journal-title":"Neural Regen Res"},{"key":"4311_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00302-4","author":"D Chen","year":"2022","unstructured":"Chen D, Lan G, Li R et al (2022) Melatonin ameliorates tau-related pathology via the mir-504-3p and CDK5 axis in Alzheimer\u2019s disease. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-022-00302-4","journal-title":"Transl Neurodegener"},{"issue":"8","key":"4311_CR115","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/jim-2016-000240","volume":"64","author":"PH Reddy","year":"2016","unstructured":"Reddy PH, Manczak M, Yin X et al (2016) Protective effects of a natural product, curcumin, against amyloid beta induced mitochondrial and synaptic toxicities in Alzheimer\u2019s disease. J Investig Med 64(8):1220\u20131234. https:\/\/doi.org\/10.1136\/jim-2016-000240","journal-title":"J Investig Med"},{"issue":"2","key":"4311_CR116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.14283\/jpad.2014.2","volume":"1","author":"S Hagl","year":"2014","unstructured":"Hagl S, Heinrich M, Kocher A, Schiborr C, Frank J, Eckert GP (2014) Curcumin micelles improve mitochondrial function in a mouse model of Alzheimer\u2019s disease. J Prev Alzheimers Dis 1(2):80\u201383. https:\/\/doi.org\/10.14283\/jpad.2014.2","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"4311_CR117","doi-asserted-by":"publisher","first-page":"895","DOI":"10.31083\/j.jin2004091","volume":"20","author":"M Tian","year":"2021","unstructured":"Tian M, Zhou F, Teng Z et al (2021) Curcumin ameliorates lipid metabolic disorder and cognitive dysfunction via the ABCA1 transmembrane transport system in APP\/PS1 double transgenic mice. J Integr Neurosci 20(4):895\u2013903. https:\/\/doi.org\/10.31083\/j.jin2004091","journal-title":"J Integr Neurosci"},{"issue":"2","key":"4311_CR118","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-160289","volume":"55","author":"R Mcclure","year":"2017","unstructured":"Mcclure R, Ong H, Janve V et al (2017) Aerosol delivery of curcumin reduced amyloid-beta deposition and improved cognitive performance in a transgenic model of Alzheimer\u2019s disease. J Alzheimers Dis 55(2):797\u2013811. https:\/\/doi.org\/10.3233\/JAD-160289","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"4311_CR119","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3969\/j.issn.1673-5374.2011.24.001","volume":"6","author":"Y Wang","year":"2011","unstructured":"Wang Y, Yin H, Lou J et al (2011) Effects of curcumin on hippocampal bax and bcl-2 expression and cognitive function of a rat model of Alzheimer\u2019s disease. Neural Regen Res 6(24):1845\u20131849. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2011.24.001","journal-title":"Neural Regen Res"},{"issue":"1","key":"4311_CR120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0394632016688025","volume":"30","author":"P Wang","year":"2017","unstructured":"Wang P, Su C, Feng H et al (2017) Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe\/PS1de9 mice. Int J Immunopathol Pharmacol 30(1):25\u201343. https:\/\/doi.org\/10.1177\/0394632016688025","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"4311_CR121","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JAD-170512","volume":"61","author":"PH Reddy","year":"2018","unstructured":"Reddy PH, Manczak M, Yin X et al (2018) Protective effects of Indian spice curcumin against amyloid\u2014\u03b2 in Alzheimer\u2019s disease. J Alzheimers Dis 61(3):843\u2013866. https:\/\/doi.org\/10.3233\/JAD-170512","journal-title":"J Alzheimers Dis"},{"key":"4311_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105123","author":"S Lou","year":"2024","unstructured":"Lou S, Gong D, Yang M, Qiu Q, Luo J, Chen T (2024) Curcumin improves neurogenesis in Alzheimer\u2019s disease mice via the upregulation of wnt\/\u03b2-catenin and BDNF. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25105123","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4311_CR123","first-page":"12204","volume":"11","author":"Z Liu","year":"2018","unstructured":"Liu Z, Jiang Y, Wang Y, Gao H, Chen Z, Fang L (2018) Curcumin improves learning and memory ability via inhibiting activated microglia-mediated inflammation in mouse models of Alzheimer\u2019s disease. Int J Clin Exp Med 11(11):12204\u201312210","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"4311_CR124","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/ADR-190135","volume":"3","author":"TK Das","year":"2019","unstructured":"Das TK, Jana P, Chakrabarti SK, Hamid MRWA (2019) Curcumin downregulates GSK3 and cdk5 in scopolamine-induced Alzheimer\u2019s disease rats abrogating a\u03b2 40\/42 and tau hyperphosphorylation. J Alzheimers Dis Rep 3(1):257\u2013267. https:\/\/doi.org\/10.3233\/ADR-190135","journal-title":"J Alzheimers Dis Rep"},{"issue":"1","key":"4311_CR125","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","volume":"8","author":"SK Tiwari","year":"2014","unstructured":"Tiwari SK, Agarwal S, Seth B et al (2014) Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical wnt\/beta-catenin pathway. ACS Nano 8(1):76\u2013103. https:\/\/doi.org\/10.1021\/nn405077y","journal-title":"ACS Nano"},{"key":"4311_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00261","author":"ZJ Liu","year":"2016","unstructured":"Liu ZJ, Li ZH, Liu L et al (2016) Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2016.00261","journal-title":"Front Pharmacol"},{"issue":"3","key":"4311_CR127","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s12035-016-9802-9","volume":"54","author":"K Zheng","year":"2017","unstructured":"Zheng K, Dai X, Xiao N et al (2017) Curcumin ameliorates memory decline via inhibiting BACE1 expression and beta-amyloid pathology in 5xFAD transgenic mice. Mol Neurobiol 54(3):1967\u20131977. https:\/\/doi.org\/10.1007\/s12035-016-9802-9","journal-title":"Mol Neurobiol"},{"issue":"3","key":"4311_CR128","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/cell.2018.0027","volume":"21","author":"J Li","year":"2019","unstructured":"Li J, Han Y, Li M, Nie C (2019) Curcumin promotes proliferation of adult neural stem cells and the birth of neurons in Alzheimer\u2019s disease mice via notch signaling pathway. Cell Reprogram 21(3):152\u2013161. https:\/\/doi.org\/10.1089\/cell.2018.0027","journal-title":"Cell Reprogram"},{"issue":"8","key":"4311_CR129","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1142\/S0192415X17500902","volume":"45","author":"J Sun","year":"2017","unstructured":"Sun J, Zhang X, Wang C, Teng Z, Li Y (2017) Curcumin decreases hyperphosphorylation of tau by down-regulating caveolin-1\/GSK-3beta in n2a\/APP695swe cells and APP\/PS1 double transgenic Alzheimer\u2019s disease mice. Am J Chin Med 45(8):1667\u20131682. https:\/\/doi.org\/10.1142\/S0192415X17500902","journal-title":"Am J Chin Med"},{"issue":"2","key":"4311_CR130","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-2012-120130","volume":"32","author":"SA Farr","year":"2012","unstructured":"Farr SA, Price TO, Banks WA, Ercal N, Morley JE (2012) Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice. J Alzheimers Dis 32(2):447\u2013455. https:\/\/doi.org\/10.3233\/JAD-2012-120130","journal-title":"J Alzheimers Dis"},{"key":"4311_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031168","author":"X Pei","year":"2023","unstructured":"Pei X, Hu F, Hu Z et al (2023) Neuroprotective effect of alpha-lipoic acid against a beta(25\u201335)-induced damage in BV2 cells. Molecules. https:\/\/doi.org\/10.3390\/molecules28031168","journal-title":"Molecules"},{"key":"4311_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169186","author":"F Dieter","year":"2022","unstructured":"Dieter F, Esselun C, Eckert GP (2022) Redox active alpha-lipoic acid differentially improves mitochondrial dysfunction in a cellular model of Alzheimer and its control cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169186","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4311_CR133","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jat.4213","volume":"42","author":"X Pei","year":"2022","unstructured":"Pei X, Hu F, Luo F et al (2022) The neuroprotective effects of alpha-lipoic acid on an experimental model of Alzheimer\u2019s disease in PC12 cells. J Appl Toxicol 42(2):285\u2013294. https:\/\/doi.org\/10.1002\/jat.4213","journal-title":"J Appl Toxicol"},{"key":"4311_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2017.11.001","author":"YH Zhang","year":"2018","unstructured":"Zhang YH, Wang DW, Xu SF et al (2018) Alpha-lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in p301s tau transgenic mice. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2017.11.001","journal-title":"Redox Biol"},{"issue":"5","key":"4311_CR135","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s12031-022-01979-y","volume":"72","author":"H Staykov","year":"2022","unstructured":"Staykov H, Lazarova M, Hassanova Y, Stefanova M, Tancheva L, Nikolov R (2022) Neuromodulatory mechanisms of a memory loss-preventive effect of alpha-lipoic acid in an experimental rat model of dementia. J Mol Neurosci 72(5):1018\u20131025. https:\/\/doi.org\/10.1007\/s12031-022-01979-y","journal-title":"J Mol Neurosci"},{"issue":"2","key":"4311_CR136","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2005.12.014","volume":"28","author":"JF Quinn","year":"2007","unstructured":"Quinn JF, Bussiere JR, Hammond RS et al (2007) Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged tg2576 mice. Neurobiol Aging 28(2):213\u2013225. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.12.014","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"4311_CR137","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11010-008-9705-9","volume":"311","author":"EP Jesudason","year":"2008","unstructured":"Jesudason EP, Masilamoni JG, Ashok BS et al (2008) Inhibitory effects of short-term administration of DL-alpha-lipoic acid on oxidative vulnerability induced by abeta amyloid fibrils (25\u201335) in mice. Mol Cell Biochem 311(1\u20132):145\u2013156. https:\/\/doi.org\/10.1007\/s11010-008-9705-9","journal-title":"Mol Cell Biochem"},{"key":"4311_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0754-9","author":"Y Pan","year":"2016","unstructured":"Pan Y, Sun X, Jiang L et al (2016) Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-016-0754-9","journal-title":"J Neuroinflammation"},{"key":"4311_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01527-3","author":"J Zhang","year":"2024","unstructured":"Zhang J, Jiang Y, Dong X et al (2024) Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23\/PS45 mice through a mitophagy-mediated increase in ADAM10 \u03b1-secretase cleavage of APP. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-024-01527-3","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"4311_CR140","doi-asserted-by":"publisher","first-page":"360","DOI":"10.22038\/IJBMS.2023.73075.15879","volume":"27","author":"RAM Mehraban","year":"2024","unstructured":"Mehraban RAM, Babaei P, Rohampour K, Jafari A, Golipoor Z (2024) Metformin improves memory via AMPK\/mTOR-dependent route in a rat model of Alzheimer\u2019s disease. Iran J Basic Med Sci 27(3):360\u2013365. https:\/\/doi.org\/10.22038\/IJBMS.2023.73075.15879","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"4311_CR141","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s13311-022-01316-6","volume":"20","author":"S Zhao","year":"2023","unstructured":"Zhao S, Fan Z, Zhang X et al (2023) Metformin attenuates tau pathology in tau\u2014seeded PS19 mice. Neurotherapeutics 20(2):452\u2013463. https:\/\/doi.org\/10.1007\/s13311-022-01316-6","journal-title":"Neurotherapeutics"},{"key":"4311_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.12.009","author":"Z Ou","year":"2018","unstructured":"Ou Z, Kong X, Sun X et al (2018) Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2017.12.009","journal-title":"Brain Behav Immun"},{"issue":"4","key":"4311_CR143","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3233\/JAD-181240","volume":"68","author":"SA Farr","year":"2019","unstructured":"Farr SA, Roesler E, Niehoff ML, Roby DA, Mckee A, Morley JE (2019) Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 68(4):1699\u20131710. https:\/\/doi.org\/10.3233\/JAD-181240","journal-title":"J Alzheimers Dis"},{"key":"4311_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2315106","author":"XY Lu","year":"2020","unstructured":"Lu XY, Huang S, Chen QB et al (2020) Metformin ameliorates abeta pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2020\/2315106","journal-title":"Oxid Med Cell Longev"},{"key":"4311_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173290","author":"V Pilipenko","year":"2020","unstructured":"Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Klusa V (2020) Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer\u2019s disease. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173290","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"4311_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17873","volume":"9","author":"S Rabieipoor","year":"2023","unstructured":"Rabieipoor S, Zare M, Ettcheto M, Camins A, Javan M (2023) Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer\u2019s disease. Heliyon 9(7):e17873. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17873","journal-title":"Heliyon"},{"issue":"5","key":"4311_CR147","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bcpt.13279","volume":"125","author":"LX Li","year":"2019","unstructured":"Li LX, Liu MY, Jiang X et al (2019) Metformin inhibits abeta(25\u201335)-induced apoptotic cell death in SH-SY5y cells. Basic Clin Pharmacol Toxicol 125(5):439\u2013449. https:\/\/doi.org\/10.1111\/bcpt.13279","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"4311_CR148","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s11011-023-01170-1","volume":"38","author":"M Khaleghi-Mehr","year":"2023","unstructured":"Khaleghi-Mehr M, Delshad AA, Shafie-Damavandi S, Roghani M (2023) Metformin mitigates amyloid beta (1\u201340)-induced cognitive decline via attenuation of oxidative\/nitrosative stress and neuroinflammation. Metab Brain Dis 38(4):1127\u20131142. https:\/\/doi.org\/10.1007\/s11011-023-01170-1","journal-title":"Metab Brain Dis"},{"issue":"1","key":"4311_CR149","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-020-00761-9","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhao S, Fan Z et al (2021) Metformin attenuates plaque-associated tau pathology and reduces amyloid-beta burden in APP\/PS1 mice. Alzheimers Res Ther 13(1):40. https:\/\/doi.org\/10.1186\/s13195-020-00761-9","journal-title":"Alzheimers Res Ther"},{"key":"4311_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2017.10.002","author":"MC Chiang","year":"2018","unstructured":"Chiang MC, Nicol CJ, Cheng YC (2018) Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2017.10.002","journal-title":"Neurochem Int"},{"key":"4311_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108569","author":"S Sarroca","year":"2021","unstructured":"Sarroca S, Gatius A, Rodriguez-Farre E et al (2021) Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer\u2019s disease via modulation of proteolytic mechanisms. J Nutr Biochem. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108569","journal-title":"J Nutr Biochem"},{"issue":"2","key":"4311_CR152","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00394-015-0894-1","volume":"55","author":"C Regitz","year":"2016","unstructured":"Regitz C, Fitzenberger E, Mahn FL, Dussling LM, Wenzel U (2016) Resveratrol reduces amyloid-beta (abeta(1)(-)(4)(2))-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. Eur J Nutr 55(2):741\u2013747. https:\/\/doi.org\/10.1007\/s00394-015-0894-1","journal-title":"Eur J Nutr"},{"issue":"2","key":"4311_CR153","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-018-1157-y","volume":"56","author":"R Corpas","year":"2019","unstructured":"Corpas R, Grinan-Ferre C, Rodriguez-Farre E, Pallas M, Sanfeliu C (2019) Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. Mol Neurobiol 56(2):1502\u20131516. https:\/\/doi.org\/10.1007\/s12035-018-1157-y","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4311_CR154","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/JAD-140444","volume":"42","author":"D Porquet","year":"2014","unstructured":"Porquet D, Grinan-Ferre C, Ferrer I et al (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1209\u20131220. https:\/\/doi.org\/10.3233\/JAD-140444","journal-title":"J Alzheimers Dis"},{"key":"4311_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2017.10.021","author":"H Wang","year":"2018","unstructured":"Wang H, Jiang T, Li W, Gao N, Zhang T (2018) Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease. Toxicol Lett. https:\/\/doi.org\/10.1016\/j.toxlet.2017.10.021","journal-title":"Toxicol Lett"},{"key":"4311_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120356","author":"H Yu","year":"2022","unstructured":"Yu H, Yamashita T, Hu X et al (2022) Protective and anti-oxidative effects of curcumin and resveratrol on abeta-oligomer-induced damage in the SH-SY5y cell line. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2022.120356","journal-title":"J Neurol Sci"},{"issue":"4","key":"4311_CR157","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.3892\/mmr.2015.4199","volume":"12","author":"Y Yao","year":"2015","unstructured":"Yao Y, Li J, Niu Y et al (2015) Resveratrol inhibits oligomeric abeta-induced microglial activation via NADPH oxidase. Mol Med Rep 12(4):6133\u20136139. https:\/\/doi.org\/10.3892\/mmr.2015.4199","journal-title":"Mol Med Rep"},{"issue":"s1","key":"4311_CR158","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-161034","volume":"60","author":"M Sathya","year":"2017","unstructured":"Sathya M, Moorthi P, Premkumar P, Kandasamy M, Jayachandran KS, Anusuyadevi M (2017) Resveratrol intervenes cholesterol- and isoprenoid-mediated amyloidogenic processing of AbetaPP in familial Alzheimer\u2019s disease. J Alzheimers Dis 60(s1):S3\u2013S23. https:\/\/doi.org\/10.3233\/JAD-161034","journal-title":"J Alzheimers Dis"},{"key":"4311_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197337","author":"TL Broderick","year":"2020","unstructured":"Broderick TL, Rasool S, Li R et al (2020) Neuroprotective effects of chronic resveratrol treatment and exercise training in the 3xtg-AD mouse model of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197337","journal-title":"Int J Mol Sci"},{"key":"4311_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.08.051","author":"R Wang","year":"2017","unstructured":"Wang R, Zhang Y, Li J, Zhang C (2017) Resveratrol ameliorates spatial learning memory impairment induced by abeta(1\u201342) in rats. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.08.051","journal-title":"Neuroscience"},{"issue":"8","key":"4311_CR161","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/s0891-5849(03)00062-5","volume":"34","author":"JH Jang","year":"2003","unstructured":"Jang JH, Surh YJ (2003) Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 34(8):1100\u20131110. https:\/\/doi.org\/10.1016\/s0891-5849(03)00062-5","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"4311_CR162","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.3892\/mmr.2019.10010","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen Y, Shi GW, Liang ZM et al (2019) Resveratrol improves cognition and decreases amyloid plaque formation in tg6799 mice. Mol Med Rep 19(5):3783\u20133790. https:\/\/doi.org\/10.3892\/mmr.2019.10010","journal-title":"Mol Med Rep"},{"key":"4311_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13020177","author":"C Bartra","year":"2024","unstructured":"Bartra C, Yuan Y, Vuraic K et al (2024) Resveratrol activates antioxidant protective mechanisms in cellular models of Alzheimer\u2019s disease inflammation. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13020177","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"4311_CR164","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s11064-016-2143-2","volume":"42","author":"HN Li","year":"2017","unstructured":"Li HN, Zimmerman M, Milledge GZ et al (2017) Water-soluble coenzyme q10 reduces rotenone-induced mitochondrial fission. Neurochem Res 42(4):1096\u20131103. https:\/\/doi.org\/10.1007\/s11064-016-2143-2","journal-title":"Neurochem Res"},{"issue":"1","key":"4311_CR165","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2005.11.019","volume":"70","author":"SK Sharma","year":"2006","unstructured":"Sharma SK, El RH, Ebadi M (2006) Complex-1 activity and 18f-DOPA uptake in genetically engineered mouse model of Parkinson\u2019s disease and the neuroprotective role of coenzyme q10. Brain Res Bull 70(1):22\u201332. https:\/\/doi.org\/10.1016\/j.brainresbull.2005.11.019","journal-title":"Brain Res Bull"},{"issue":"1","key":"4311_CR166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/FBP.0000000000000342","volume":"29","author":"HN Attia","year":"2018","unstructured":"Attia HN, Maklad YA (2018) Neuroprotective effects of coenzyme q10 on paraquat-induced Parkinson\u2019s disease in experimental animals. Behav Pharmacol 29(1):79\u201386. https:\/\/doi.org\/10.1097\/FBP.0000000000000342","journal-title":"Behav Pharmacol"},{"issue":"1","key":"4311_CR167","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0006-8993(97)01192-x","volume":"783","author":"MF Beal","year":"1998","unstructured":"Beal MF, Matthews RT, Tieleman A, Shults CW (1998) Coenzyme q10 attenuates the 1-methyl-4-phenyl-1,2,3, tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 783(1):109\u2013114. https:\/\/doi.org\/10.1016\/s0006-8993(97)01192-x","journal-title":"Brain Res"},{"issue":"6","key":"4311_CR168","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","volume":"104","author":"C Cleren","year":"2008","unstructured":"Cleren C, Yang L, Lorenzo B et al (2008) Therapeutic effects of coenzyme q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104(6):1613\u20131621. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05097.x","journal-title":"J Neurochem"},{"issue":"1","key":"4311_CR169","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10072-011-0627-z","volume":"33","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Muroyama A, Matsushima H, Yoshimura I, Mitsumoto Y (2012) Oral administration of coenzyme q (1)(0) reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice. Neurol Sci 33(1):195\u2013199. https:\/\/doi.org\/10.1007\/s10072-011-0627-z","journal-title":"Neurol Sci"},{"issue":"7","key":"4311_CR170","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s11011-021-00795-4","volume":"36","author":"E Ghasemloo","year":"2021","unstructured":"Ghasemloo E, Mostafavi H, Hosseini M, Forouzandeh M, Eskandari M, Mousavi SS (2021) Neuroprotective effects of coenzyme q10 in Parkinson\u2019s model via a novel q10\/mir-149-5p\/MMPs pathway. Metab Brain Dis 36(7):2089\u20132100. https:\/\/doi.org\/10.1007\/s11011-021-00795-4","journal-title":"Metab Brain Dis"},{"issue":"4","key":"4311_CR171","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pbb.2011.06.026","volume":"99","author":"G Patki","year":"2011","unstructured":"Patki G, Lau YS (2011) Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson\u2019s disease. Pharmacol Biochem Behav 99(4):704\u2013711. https:\/\/doi.org\/10.1016\/j.pbb.2011.06.026","journal-title":"Pharmacol Biochem Behav"},{"key":"4311_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.12.036","author":"CH Carriere","year":"2016","unstructured":"Carriere CH, Kang NH, Niles LP (2016) Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.036","journal-title":"Brain Res"},{"issue":"8","key":"4311_CR173","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1021\/acsomega.2c03992","volume":"8","author":"MZ Rasheed","year":"2023","unstructured":"Rasheed MZ, Khatoon R, Talat F, Alam MM, Tabassum H, Parvez S (2023) Melatonin mitigates rotenone-induced oxidative stress and mitochondrial dysfunction in the drosophila melanogaster model of Parkinson\u2019s disease-like symptoms. ACS Omega 8(8):7279\u20137288. https:\/\/doi.org\/10.1021\/acsomega.2c03992","journal-title":"ACS Omega"},{"issue":"2","key":"4311_CR174","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018025666","volume":"37","author":"MZ Rasheed","year":"2018","unstructured":"Rasheed MZ, Andrabi SS, Salman M et al (2018) Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson\u2019s disease. J Environ Pathol Toxicol Oncol 37(2):139\u2013150","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"3","key":"4311_CR175","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","volume":"42","author":"KS Saravanan","year":"2007","unstructured":"Saravanan KS, Sindhu KM, Mohanakumar KP (2007) Melatonin protects against rotenone-induced oxidative stress in a hemi Parkinsonian rat model. J Pineal Res 42(3):247\u2013253. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00412.x","journal-title":"J Pineal Res"},{"issue":"3","key":"4311_CR176","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3892\/br.2018.1125","volume":"9","author":"D Ran","year":"2018","unstructured":"Ran D, Xie B, Gan Z, Sun X, Gu H, Yang J (2018) Melatonin attenuates hLRRK2-induced long-term memory deficit in a drosophila model of Parkinson\u2019s disease. Biomed Rep 9(3):221\u2013226. https:\/\/doi.org\/10.3892\/br.2018.1125","journal-title":"Biomed Rep"},{"issue":"2","key":"4311_CR177","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jpi.12343","volume":"61","author":"JI Chuang","year":"2016","unstructured":"Chuang JI, Pan IL, Hsieh CY, Huang CY, Chen PC, Shin JW (2016) Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment. J Pineal Res 61(2):230\u2013240. https:\/\/doi.org\/10.1111\/jpi.12343","journal-title":"J Pineal Res"},{"key":"4311_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.09.068","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T et al (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2014.09.068","journal-title":"Brain Res"},{"issue":"2","key":"4311_CR179","doi-asserted-by":"publisher","first-page":"PL23","DOI":"10.1016\/s0024-3205(96)00606-6","volume":"60","author":"D Acuna-Castroviejo","year":"1997","unstructured":"Acuna-Castroviejo D, Coto-Montes A, Gaia MM, Ortiz GG, Reiter RJ (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 60(2):PL23\u2013PL29. https:\/\/doi.org\/10.1016\/s0024-3205(96)00606-6","journal-title":"Life Sci"},{"key":"4311_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.06.099","author":"YJ Jung","year":"2022","unstructured":"Jung YJ, Choi H, Oh E (2022) Melatonin attenuates MPP (+)-induced apoptosis via heat shock protein in a Parkinson\u2019s disease model. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.099","journal-title":"Biochem Biophys Res Commun"},{"key":"4311_CR181","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5577541","author":"A Jimenez-Delgado","year":"2021","unstructured":"Jimenez-Delgado A, Ortiz GG, Delgado-Lara DL et al (2021) Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with Parkinson\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2021\/5577541","journal-title":"Oxid Med Cell Longev"},{"key":"4311_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.016","author":"R Paul","year":"2018","unstructured":"Paul R, Phukan BC, Justin TA, Manivasagam T, Bhattacharya P, Borah A (2018) Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson\u2019s disease. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.016","journal-title":"Life Sci"},{"issue":"5","key":"4311_CR183","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/s1734-1140(13)71479-8","volume":"65","author":"SA Zaitone","year":"2013","unstructured":"Zaitone SA, Hammad LN, Farag NE (2013) Antioxidant potential of melatonin enhances the response to l-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-Parkinsonian mice. Pharmacol Rep 65(5):1213\u20131226. https:\/\/doi.org\/10.1016\/s1734-1140(13)71479-8","journal-title":"Pharmacol Rep"},{"issue":"5","key":"4311_CR184","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.3892\/mmr.2016.4991","volume":"13","author":"X Sun","year":"2016","unstructured":"Sun X, Ran D, Zhao X et al (2016) Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a drosophila model of Parkinson\u2019s disease. Mol Med Rep 13(5):3936\u20133944. https:\/\/doi.org\/10.3892\/mmr.2016.4991","journal-title":"Mol Med Rep"},{"issue":"1","key":"4311_CR185","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","volume":"1068","author":"R Sharma","year":"2006","unstructured":"Sharma R, Mcmillan CR, Tenn CC, Niles LP (2006) Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson\u2019s disease. Brain Res 1068(1):230\u2013236. https:\/\/doi.org\/10.1016\/j.brainres.2005.10.084","journal-title":"Brain Res"},{"key":"4311_CR186","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S317672","author":"R Zheng","year":"2021","unstructured":"Zheng R, Ruan Y, Yan Y et al (2021) Melatonin attenuates neuroinflammation by down-regulating NLRP3 inflammasome via a SIRT1-dependent pathway in MPTP-induced models of Parkinson\u2019s disease. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S317672","journal-title":"J Inflamm Res"},{"issue":"1","key":"4311_CR187","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","volume":"8","author":"J Li","year":"2022","unstructured":"Li J, Liu H, Wang X et al (2022) Melatonin ameliorates Parkinson\u2019s disease via regulating microglia polarization in a RO-Ralpha-dependent pathway. NPJ Parkinsons Dis 8(1):90. https:\/\/doi.org\/10.1038\/s41531-022-00352-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"4311_CR188","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12031-020-01760-z","volume":"71","author":"L Tancheva","year":"2021","unstructured":"Tancheva L, Lazarova M, Saso L et al (2021) Beneficial effect of melatonin on motor and memory disturbances in 6-OHDA-lesioned rats. J Mol Neurosci 71(4):702\u2013712. https:\/\/doi.org\/10.1007\/s12031-020-01760-z","journal-title":"J Mol Neurosci"},{"key":"4311_CR189","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S462333","author":"B Cai","year":"2024","unstructured":"Cai B, Wang Q, Zhong L, Liu F, Wang X, Chen T (2024) Integrating network pharmacology, transcriptomics to reveal neuroprotective of curcumin activate PI3k\/AKT pathway in Parkinson\u2019s disease. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S462333","journal-title":"Drug Des Devel Ther"},{"key":"4311_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105297","author":"HJ He","year":"2022","unstructured":"He HJ, Xiong X, Zhou S et al (2022) Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson\u2019s models. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2022.105297","journal-title":"Neurochem Int"},{"key":"4311_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1198335","author":"B Cai","year":"2023","unstructured":"Cai B, Zhong L, Wang Q, Xu W, Li X, Chen T (2023) Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson\u2019s disease in mice via modulating gut microbiota and short-chain fatty acids. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1198335","journal-title":"Front Pharmacol"},{"issue":"5","key":"4311_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16195","volume":"9","author":"L Xu","year":"2023","unstructured":"Xu L, Hao LP, Yu J et al (2023) Curcumin protects against rotenone-induced Parkinson\u2019s disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction. Heliyon 9(5):e16195. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16195","journal-title":"Heliyon"},{"key":"4311_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197329","author":"NE El","year":"2020","unstructured":"El NE, Javed H, Ojha SK, Oz M, Shehab S (2020) Neuroprotective effect of curcumin on the nigrostriatal pathway in a 6-hydroxydopmine-induced rat model of Parkinson\u2019s disease is mediated by alpha7-nicotinic receptors. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197329","journal-title":"Int J Mol Sci"},{"key":"4311_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2016.09.002","author":"DK Khatri","year":"2016","unstructured":"Khatri DK, Juvekar AR (2016) Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson\u2019s disease. Pharmacol Biochem Behav. https:\/\/doi.org\/10.1016\/j.pbb.2016.09.002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4311_CR195","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2047-9158-1-16","volume":"1","author":"J Pan","year":"2012","unstructured":"Pan J, Li H, Ma JF et al (2012) Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease through suppressing mitochondria dysfunction. Transl Neurodegener 1(1):16. https:\/\/doi.org\/10.1186\/2047-9158-1-16","journal-title":"Transl Neurodegener"},{"issue":"4","key":"4311_CR196","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1007\/s12035-016-9843-0","volume":"54","author":"C van der Merwe","year":"2017","unstructured":"van der Merwe C, van Dyk HC, Engelbrecht L et al (2017) Curcumin rescues a PINK1 knock down SH-SY5y cellular model of Parkinson\u2019s disease from mitochondrial dysfunction and cell death. Mol Neurobiol 54(4):2752\u20132762. https:\/\/doi.org\/10.1007\/s12035-016-9843-0","journal-title":"Mol Neurobiol"},{"issue":"6","key":"4311_CR197","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.prp.2014.02.005","volume":"210","author":"J Yang","year":"2014","unstructured":"Yang J, Song S, Li J, Liang T (2014) Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson\u2019s disease rat. Pathol Res Pract 210(6):357\u2013362. https:\/\/doi.org\/10.1016\/j.prp.2014.02.005","journal-title":"Pathol Res Pract"},{"issue":"5","key":"4311_CR198","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cns.13805","volume":"28","author":"H Fikry","year":"2022","unstructured":"Fikry H, Saleh LA, Abdel GS (2022) Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson\u2019s disease model. CNS Neurosci Ther 28(5):732\u2013748. https:\/\/doi.org\/10.1111\/cns.13805","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"4311_CR199","first-page":"2654","volume":"9","author":"X Xia","year":"2016","unstructured":"Xia X, Lian Y, Zhao H, Xu Q (2016) Curcumin protects from oxidative stress and inhibits \u03b1-synuclein aggregation in MPTP induced Parkinsonian mice. Int J Clin Exp Med 9(2):2654\u20132665","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"4311_CR200","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","volume":"26","author":"N Sharma","year":"2018","unstructured":"Sharma N, Nehru B (2018) Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson\u2019s disease model. Inflammopharmacology 26(2):349\u2013360. https:\/\/doi.org\/10.1007\/s10787-017-0402-8","journal-title":"Inflammopharmacology"},{"issue":"5","key":"4311_CR201","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.phrs.2011.01.004","volume":"63","author":"Z Liu","year":"2011","unstructured":"Liu Z, Yu Y, Li X, Ross CA, Smith WW (2011) Curcumin protects against a53t alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Pharmacol Res 63(5):439\u2013444. https:\/\/doi.org\/10.1016\/j.phrs.2011.01.004","journal-title":"Pharmacol Res"},{"issue":"4","key":"4311_CR202","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1293\/tox.28.2015-0020","volume":"28","author":"X He","year":"2015","unstructured":"He X, Uchida K, Megumi C, Tsuge N, Nakayama H (2015) Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in c57BL mice. J Toxicol Pathol 28(4):197\u2013206. https:\/\/doi.org\/10.1293\/tox.28.2015-0020","journal-title":"J Toxicol Pathol"},{"key":"4311_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.04.009","author":"L Zhou","year":"2019","unstructured":"Zhou L, Cheng Y (2019) Alpha-lipoic acid alleviated 6-OHDA-induced cell damage by inhibiting AMPK\/mTOR mediated autophagy. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.04.009","journal-title":"Neuropharmacology"},{"key":"4311_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/571378","author":"DP de Araujo","year":"2013","unstructured":"de Araujo DP, De Sousa CNS, Araujo PVP et al (2013) Behavioral and neurochemical effects of alpha-lipoic acid in the model of Parkinson\u2019s disease induced by unilateral stereotaxic injection of 6-ohda in rat. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2013\/571378","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"4311_CR205","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12640-022-00479-6","volume":"40","author":"J Zhang","year":"2022","unstructured":"Zhang J, Gao Y, Zhang L et al (2022) Alpha-lipoic acid attenuates MPTP\/MPP+-induced neurotoxicity: roles of SIRT1-dependent PGC-1\u03b1 signaling pathways. Neurotox Res 40(2):410\u2013419. https:\/\/doi.org\/10.1007\/s12640-022-00479-6","journal-title":"Neurotox Res"},{"key":"4311_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00612","author":"S Tai","year":"2020","unstructured":"Tai S, Zheng Q, Zhai S et al (2020) Alpha-lipoic acid mediates clearance of iron accumulation by regulating iron metabolism in a Parkinson\u2019s disease model induced by 6-OHDA. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00612","journal-title":"Front Neurosci"},{"key":"4311_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2013.01.054","author":"M Jalali-Nadoushan","year":"2013","unstructured":"Jalali-Nadoushan M, Roghani M (2013) Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-Parkinsonism. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2013.01.054","journal-title":"Brain Res"},{"key":"4311_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176878","author":"MI Fahmy","year":"2024","unstructured":"Fahmy MI, Khalaf SS, Elrayess RA (2024) The neuroprotective effects of alpha lipoic acid in rotenone-induced Parkinson\u2019s disease in mice via activating PI3k\/AKT pathway and antagonizing related inflammatory cascades. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176878","journal-title":"Eur J Pharmacol"},{"key":"4311_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136669","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang M, Zhao Y et al (2022) Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2022.136669","journal-title":"Neurosci Lett"},{"issue":"2","key":"4311_CR210","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cbin.11505","volume":"45","author":"L Liu","year":"2021","unstructured":"Liu L, Yang S, Wang H (2021) \u03b1-lipoic acid alleviates ferroptosis in the MPP+-induced PC12 cells via activating the PI3k\/akt\/nrf2 pathway. Cell Biol Int 45(2):422\u2013431. https:\/\/doi.org\/10.1002\/cbin.11505","journal-title":"Cell Biol Int"},{"issue":"1","key":"4311_CR211","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3892\/mmr.2017.7974","volume":"17","author":"S Zhang","year":"2018","unstructured":"Zhang S, Xie C, Lin J, Wang M, Wang X, Liu Z (2018) Lipoic acid alleviates l-DOPA-induced dyskinesia in 6-OHDA Parkinsonian rats via anti-oxidative stress. Mol Med Rep 17(1):1118\u20131124. https:\/\/doi.org\/10.3892\/mmr.2017.7974","journal-title":"Mol Med Rep"},{"key":"4311_CR212","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw047","author":"M Lu","year":"2016","unstructured":"Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G (2016) Metformin prevents dopaminergic neuron death in MPTP\/p-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyw047","journal-title":"Int J Neuropsychopharmacol"},{"key":"4311_CR213","doi-asserted-by":"publisher","DOI":"10.17179\/excli2019-1703","author":"P Chanthammachat","year":"2019","unstructured":"Chanthammachat P, Dharmasaroja P (2019) Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5y cells. EXCLI J. https:\/\/doi.org\/10.17179\/excli2019-1703","journal-title":"EXCLI J"},{"key":"4311_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.08.015","author":"N Katila","year":"2017","unstructured":"Katila N, Bhurtel S, Shadfar S et al (2017) Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.015","journal-title":"Neuropharmacology"},{"issue":"1","key":"4311_CR215","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-024-03072-0","volume":"21","author":"M Wang","year":"2024","unstructured":"Wang M, Tian T, Zhou H et al (2024) Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson\u2019s disease through mfn2-cGAS signaling. J Neuroinflammation 21(1):81. https:\/\/doi.org\/10.1186\/s12974-024-03072-0","journal-title":"J Neuroinflammation"},{"issue":"5","key":"4311_CR216","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s10787-022-01043-6","volume":"30","author":"IP Mendonca","year":"2022","unstructured":"Mendonca IP, de Paiva I, Duarte-Silva EP et al (2022) Metformin improves depressive-like behavior in experimental Parkinson\u2019s disease by inducing autophagy in the substantia nigra and hippocampus. Inflammopharmacology 30(5):1705\u20131716. https:\/\/doi.org\/10.1007\/s10787-022-01043-6","journal-title":"Inflammopharmacology"},{"issue":"7","key":"4311_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159381","volume":"11","author":"JA Bayliss","year":"2016","unstructured":"Bayliss JA, Lemus MB, Santos VV et al (2016) Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons. PLoS ONE 11(7):e0159381. https:\/\/doi.org\/10.1371\/journal.pone.0159381","journal-title":"PLoS ONE"},{"key":"4311_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105120","author":"N Katila","year":"2021","unstructured":"Katila N, Bhurtel S, Park PH, Choi DY (2021) Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT\/nrf2 pathway. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2021.105120","journal-title":"Neurochem Int"},{"issue":"9","key":"4311_CR219","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awx202","volume":"140","author":"JC Fitzgerald","year":"2017","unstructured":"Fitzgerald JC, Zimprich A, Carvajal BD et al (2017) Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson\u2019s disease. Brain 140(9):2444\u20132459. https:\/\/doi.org\/10.1093\/brain\/awx202","journal-title":"Brain"},{"issue":"5","key":"4311_CR220","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/15376516.2020.1741053","volume":"30","author":"DX Wang","year":"2020","unstructured":"Wang DX, Chen AD, Wang QJ, Xin YY, Yin J, Jing YH (2020) Protective effect of metformin against rotenone-induced Parkinsonism in mice. Toxicol Mech Methods 30(5):350\u2013357. https:\/\/doi.org\/10.1080\/15376516.2020.1741053","journal-title":"Toxicol Mech Methods"},{"issue":"5","key":"4311_CR221","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s43440-020-00095-1","volume":"72","author":"G Ozbey","year":"2020","unstructured":"Ozbey G, Nemutlu-Samur D, Parlak H et al (2020) Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. Pharmacol Rep 72(5):1397\u20131406. https:\/\/doi.org\/10.1007\/s43440-020-00095-1","journal-title":"Pharmacol Rep"},{"issue":"6","key":"4311_CR222","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1124\/mol.117.109512","volume":"92","author":"Q Yan","year":"2017","unstructured":"Yan Q, Han C, Wang G, Waddington JL, Zheng L, Zhen X (2017) Activation of AMPK\/mTORC1-mediated autophagy by metformin reverses clk1 deficiency-sensitized dopaminergic neuronal death. Mol Pharmacol 92(6):640\u2013652. https:\/\/doi.org\/10.1124\/mol.117.109512","journal-title":"Mol Pharmacol"},{"key":"4311_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00084","author":"SH El-Ghaiesh","year":"2020","unstructured":"El-Ghaiesh SH, Bahr HI, Ibrahiem AT et al (2020) Metformin protects from rotenone-induced nigrostriatal neuronal death in adult mice by activating AMPK-FOXO3 signaling and mitigation of angiogenesis. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2020.00084","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"4311_CR224","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1039\/c8fo00964c","volume":"9","author":"LF Zhang","year":"2018","unstructured":"Zhang LF, Yu XL, Ji M et al (2018) Resveratrol alleviates motor and cognitive deficits and neuropathology in the a53t alpha-synuclein mouse model of Parkinson\u2019s disease. Food Funct 9(12):6414\u20136426. https:\/\/doi.org\/10.1039\/c8fo00964c","journal-title":"Food Funct"},{"issue":"1\u20133","key":"4311_CR225","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","volume":"600","author":"F Jin","year":"2008","unstructured":"Jin F, Wu Q, Lu YF, Gong QH, Shi JS (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats. Eur J Pharmacol 600(1\u20133):78\u201382. https:\/\/doi.org\/10.1016\/j.ejphar.2008.10.005","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4311_CR226","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5214\/ans.0972-7531.1017304","volume":"17","author":"A Anandhan","year":"2010","unstructured":"Anandhan A, Tamilselvam K, Vijayraja D, Ashokkumar N, Rajasankar S, Manivasagam T (2010) Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice. Ann Neurosci 17(3):113\u2013119. https:\/\/doi.org\/10.5214\/ans.0972-7531.1017304","journal-title":"Ann Neurosci"},{"issue":"4","key":"4311_CR227","doi-asserted-by":"publisher","first-page":"959","DOI":"10.36468\/pharmaceutical-sciences.990","volume":"84","author":"H Qiu","year":"2022","unstructured":"Qiu H, Dong Y, Wang Z, Yan Z, Wu C, Yang T (2022) Neuroprotective effects of resveratrol on a mouse model of Parkinson\u2019s disease via the wnt\/beta-catenin signaling pathway. Indian J Pharm Sci 84(4):959\u2013968. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.990","journal-title":"Indian J Pharm Sci"},{"issue":"16","key":"4311_CR228","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1021\/jf8007212","volume":"56","author":"K Lu","year":"2008","unstructured":"Lu K, Ko M, Chen B et al (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56(16):6910\u20136913. https:\/\/doi.org\/10.1021\/jf8007212","journal-title":"J Agric Food Chem"},{"issue":"3","key":"4311_CR229","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000328516","volume":"19","author":"Y Wu","year":"2011","unstructured":"Wu Y, Li X, Zhu JX et al (2011) Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson\u2019s disease. Neurosignals 19(3):163\u2013174. https:\/\/doi.org\/10.1159\/000328516","journal-title":"Neurosignals"},{"issue":"9","key":"4311_CR230","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/WNR.0000000000000789","volume":"28","author":"X Zhao","year":"2017","unstructured":"Zhao X, Wang J, Hu S, Wang R, Mao Y, Xie J (2017) Neuroprotective effect of resveratrol on rotenone-treated c57BL\/6 mice. NeuroReport 28(9):498\u2013505. https:\/\/doi.org\/10.1097\/WNR.0000000000000789","journal-title":"NeuroReport"},{"issue":"1","key":"4311_CR231","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/ijms15011625","volume":"15","author":"TK Lin","year":"2014","unstructured":"Lin TK, Chen SD, Chuang YC et al (2014) Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci 15(1):1625\u20131646. https:\/\/doi.org\/10.3390\/ijms15011625","journal-title":"Int J Mol Sci"},{"key":"4311_CR232","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6705621","author":"K Peng","year":"2016","unstructured":"Peng K, Tao Y, Zhang J et al (2016) Resveratrol regulates mitochondrial biogenesis and fission\/fusion to attenuate rotenone-induced neurotoxicity. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2016\/6705621","journal-title":"Oxid Med Cell Longev"},{"key":"4311_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.11.054","author":"W Zeng","year":"2017","unstructured":"Zeng W, Zhang W, Lu F, Gao L, Gao G (2017) Resveratrol attenuates MPP (+)-induced mitochondrial dysfunction and cell apoptosis via AKT\/GSK-3beta pathway in SN4741 cells. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2016.11.054","journal-title":"Neurosci Lett"},{"issue":"4","key":"4311_CR234","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060654","volume":"8","author":"CY Chang","year":"2013","unstructured":"Chang CY, Choi DK, Lee DK, Hong YJ, Park EJ (2013) Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS ONE 8(4):e60654. https:\/\/doi.org\/10.1371\/journal.pone.0060654","journal-title":"PLoS ONE"},{"key":"4311_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110653","author":"N Huang","year":"2019","unstructured":"Huang N, Zhang Y, Chen M et al (2019) Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3k\/akt signaling pathway. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2019.110653","journal-title":"Exp Gerontol"},{"issue":"2","key":"4311_CR236","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme q10. Ann Neurol 41(2):160\u2013165. https:\/\/doi.org\/10.1002\/ana.410410206","journal-title":"Ann Neurol"},{"issue":"5","key":"4311_CR237","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A et al (2002) Therapeutic effects of coenzyme q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22(5):1592\u20131599. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-05-01592.2002","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"4311_CR238","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2013.01.007","volume":"701","author":"WE Antunes","year":"2013","unstructured":"Antunes WE, Ricardo JC, Folharini BC, Wayne NC (2013) Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington\u2019s disease: protective effect of melatonin. Eur J Pharmacol 701(1\u20133):65\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.007","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4311_CR239","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","volume":"37","author":"I Tunez","year":"2004","unstructured":"Tunez I, Montilla P, Del CMM, Feijoo M, Salcedo M (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease. J Pineal Res 37(4):252\u2013256. https:\/\/doi.org\/10.1111\/j.1600-079X.2004.00163.x","journal-title":"J Pineal Res"},{"issue":"1","key":"4311_CR240","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/07420528.2020.1842752","volume":"38","author":"MI Khyati","year":"2021","unstructured":"Khyati MI, Agrawal N, Kumar V (2021) Melatonin and curcumin reestablish disturbed circadian gene expressions and restore locomotion ability and eclosion behavior in drosophila model of Huntington\u2019s disease. Chronobiol Int 38(1):61\u201378. https:\/\/doi.org\/10.1080\/07420528.2020.1842752","journal-title":"Chronobiol Int"},{"issue":"8","key":"4311_CR241","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.pnpbp.2011.09.005","volume":"35","author":"I Tasset","year":"2011","unstructured":"Tasset I, Aguera E, Olmo-Camacho R et al (2011) Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels. Prog Neuropsychopharmacol Biol Psychiatry 35(8):1944\u20131949. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.09.005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4311_CR242","doi-asserted-by":"publisher","DOI":"10.1038\/srep18736","author":"A Chongtham","year":"2016","unstructured":"Chongtham A, Agrawal N (2016) Curcumin modulates cell death and is protective in Huntington\u2019s disease model. Sci Rep. https:\/\/doi.org\/10.1038\/srep18736","journal-title":"Sci Rep"},{"issue":"2","key":"4311_CR243","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/15353702211046927","volume":"247","author":"K Aditi","year":"2022","unstructured":"Aditi K, Singh A, Shakarad MN, Agrawal N (2022) Management of altered metabolic activity in drosophila model of Huntington\u2019s disease by curcumin. Exp Biol Med (Maywood) 247(2):152\u2013164. https:\/\/doi.org\/10.1177\/15353702211046927","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"4311_CR244","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JHD-230595","volume":"12","author":"J Dhankhar","year":"2023","unstructured":"Dhankhar J, Shrivastava A, Agrawal N (2023) Amendment of altered immune response by curcumin in drosophila model of Huntington\u2019s disease. J Huntingtons Dis 12(4):335\u2013354. https:\/\/doi.org\/10.3233\/JHD-230595","journal-title":"J Huntingtons Dis"},{"key":"4311_CR245","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249542","author":"A Gharaibeh","year":"2020","unstructured":"Gharaibeh A, Maiti P, Culver R et al (2020) Solid lipid curcumin particles protect medium spiny neuronal morphology, and reduce learning and memory deficits in the YAC128 mouse model of Huntington\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21249542","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4311_CR246","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12017-013-8261-y","volume":"16","author":"R Sandhir","year":"2014","unstructured":"Sandhir R, Yadav A, Mehrotra A, Sunkaria A, Singh A, Sharma S (2014) Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington\u2019s disease. Neuromol Med 16(1):106\u2013118. https:\/\/doi.org\/10.1007\/s12017-013-8261-y","journal-title":"Neuromol Med"},{"issue":"15","key":"4311_CR247","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","volume":"12","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Dedeoglu A, Beal MF (2001) Lipoic acid improves survival in transgenic mouse models of Huntington\u2019s disease. NeuroReport 12(15):3371\u20133373. https:\/\/doi.org\/10.1097\/00001756-200110290-00044","journal-title":"NeuroReport"},{"issue":"1\u20132","key":"4311_CR248","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11010-015-2561-5","volume":"410","author":"A Mehrotra","year":"2015","unstructured":"Mehrotra A, Sood A, Sandhir R (2015) Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington\u2019s disease. Mol Cell Biochem 410(1\u20132):281\u2013292. https:\/\/doi.org\/10.1007\/s11010-015-2561-5","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"4311_CR249","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","volume":"411","author":"TC Ma","year":"2007","unstructured":"Ma TC, Buescher JL, Oatis B et al (2007) Metformin therapy in a transgenic mouse model of Huntington\u2019s disease. Neurosci Lett 411(2):98\u2013103. https:\/\/doi.org\/10.1016\/j.neulet.2006.10.039","journal-title":"Neurosci Lett"},{"issue":"6","key":"4311_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0264-9","volume":"51","author":"A Sanchis","year":"2019","unstructured":"Sanchis A, Garcia-Gimeno MA, Canada-Martinez AJ et al (2019) Metformin treatment reduces motor and neuropsychiatric phenotypes in the zq175 mouse model of Huntington disease. Exp Mol Med 51(6):1\u201316. https:\/\/doi.org\/10.1038\/s12276-019-0264-9","journal-title":"Exp Mol Med"},{"key":"4311_CR251","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38744","author":"I Arnoux","year":"2018","unstructured":"Arnoux I, Willam M, Griesche N et al (2018) Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease. Elife. https:\/\/doi.org\/10.7554\/eLife.38744","journal-title":"Elife"},{"issue":"4","key":"4311_CR252","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12017-016-8412-z","volume":"18","author":"J Jin","year":"2016","unstructured":"Jin J, Gu H, Anders NM et al (2016) Metformin protects cells from mutant huntingtin toxicity through activation of AMPK and modulation of mitochondrial dynamics. Neuromol Med 18(4):581\u2013592. https:\/\/doi.org\/10.1007\/s12017-016-8412-z","journal-title":"Neuromol Med"},{"issue":"6","key":"4311_CR253","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/hmg\/ddv513","volume":"25","author":"RP Vazquez-Manrique","year":"2016","unstructured":"Vazquez-Manrique RP, Farina F, Cambon K et al (2016) AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington\u2019s disease. Hum Mol Genet 25(6):1043\u20131058. https:\/\/doi.org\/10.1093\/hmg\/ddv513","journal-title":"Hum Mol Genet"},{"issue":"5\u20136","key":"4311_CR254","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","volume":"17","author":"P Kumar","year":"2006","unstructured":"Kumar P, Padi SS, Naidu PS, Kumar A (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17(5\u20136):485\u2013492. https:\/\/doi.org\/10.1097\/00008877-200609000-00014","journal-title":"Behav Pharmacol"},{"key":"4311_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2017.05.013","author":"C Vidoni","year":"2018","unstructured":"Vidoni C, Secomandi E, Castiglioni A, Melone M, Isidoro C (2018) Resveratrol protects neuronal-like cells expressing mutant huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2017.05.013","journal-title":"Neurochem Int"},{"issue":"9","key":"4311_CR256","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1093\/brain\/awad099","volume":"146","author":"I Manolaras","year":"2023","unstructured":"Manolaras I, Del BA, Griso O et al (2023) Mitochondrial dysfunction and calcium dysregulation in COQ8a-ataxia purkinje neurons are rescued by CoQ10 treatment. Brain 146(9):3836\u20133850. https:\/\/doi.org\/10.1093\/brain\/awad099","journal-title":"Brain"},{"key":"4311_CR257","doi-asserted-by":"publisher","DOI":"10.1186\/s40673-019-0109-2","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi T, Favetta M, Romano A et al (2019) One-year outcome of coenzyme q10 supplementation in ADCK3 ataxia (ARCA2). Cerebellum Ataxias. https:\/\/doi.org\/10.1186\/s40673-019-0109-2","journal-title":"Cerebellum Ataxias"},{"issue":"12","key":"4311_CR258","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20165805","volume":"49","author":"CM Lopes-Ramos","year":"2016","unstructured":"Lopes-Ramos CM, Pereira TC, Dogini DB, Gilioli R, Lopes-Cendes I (2016) Lithium carbonate and coenzyme q10 reduce cell death in a cell model of machado-joseph disease. Braz J Med Biol Res 49(12):e5805. https:\/\/doi.org\/10.1590\/1414-431X20165805","journal-title":"Braz J Med Biol Res"},{"key":"4311_CR259","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173593","author":"YL Wu","year":"2022","unstructured":"Wu YL, Chang JC, Sun HL et al (2022) Coenzyme q10 supplementation increases removal of the ATXN3 polyglutamine repeat, reducing cerebellar degeneration and improving motor dysfunction in murine spinocerebellar ataxia type 3. Nutrients. https:\/\/doi.org\/10.3390\/nu14173593","journal-title":"Nutrients"},{"issue":"4","key":"4311_CR260","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archneur.62.4.621","volume":"62","author":"PE Hart","year":"2005","unstructured":"Hart PE, Lodi R, Rajagopalan B et al (2005) Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 62(4):621\u2013626. https:\/\/doi.org\/10.1001\/archneur.62.4.621","journal-title":"Arch Neurol"},{"key":"4311_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2019.101706","author":"M Mahmoudi","year":"2019","unstructured":"Mahmoudi M, Bayat AH, Boroujeni ME et al (2019) Curcumin protects purkinje neurons, ameliorates motor function and reduces cerebellar atrophy in rat model of cerebellar ataxia induced by 3-AP. J Chem Neuroanat. https:\/\/doi.org\/10.1016\/j.jchemneu.2019.101706","journal-title":"J Chem Neuroanat"},{"key":"4311_CR262","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00295","author":"AK Verma","year":"2020","unstructured":"Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A (2020) Curcumin regulates the r(CGG)(exp) RNA hairpin structure and ameliorate defects in fragile x-associated tremor ataxia syndrome. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00295","journal-title":"Front Neurosci"},{"issue":"1","key":"4311_CR263","doi-asserted-by":"publisher","first-page":"155","DOI":"10.26402\/jpp.2020.1.15","volume":"71","author":"J Yoon","year":"2020","unstructured":"Yoon J, Lee H, Lim JW, Kim H (2020) Inhibitory effect of alpha-lipoic acid on mitochondrial dysfunction and interleukin-8 expression in interleukin-1beta-stimulated ataxia telangiectasia fibroblasts. J Physiol Pharmacol 71(1):155\u2013165. https:\/\/doi.org\/10.26402\/jpp.2020.1.15","journal-title":"J Physiol Pharmacol"},{"issue":"8","key":"4311_CR264","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1007\/s12035-023-03892-w","volume":"61","author":"TC Atella","year":"2024","unstructured":"Atella TC, Medina JM, Atella GC, Allodi S, Kluck GEG (2024) Neuroprotective effects of metformin through AMPK activation in a neurotoxin-based model of cerebellar ataxia. Mol Neurobiol 61(8):5102\u20135116. https:\/\/doi.org\/10.1007\/s12035-023-03892-w","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4311_CR265","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12031-018-1065-7","volume":"65","author":"Z Ghorbani","year":"2018","unstructured":"Ghorbani Z, Farahani RM, Aliaghaei A et al (2018) Resveratrol protects purkinje neurons and restores muscle activity in rat model of cerebellar ataxia. J Mol Neurosci 65(1):35\u201342. https:\/\/doi.org\/10.1007\/s12031-018-1065-7","journal-title":"J Mol Neurosci"},{"key":"4311_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.12.011","author":"Y Wu","year":"2018","unstructured":"Wu Y, Chang J, Lin W et al (2018) Caffeic acid and resveratrol ameliorate cellular damage in cell and drosophila models of spinocerebellar ataxia type 3 through upregulation of nrf2 pathway. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.12.011","journal-title":"Free Radic Biol Med"},{"key":"4311_CR267","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11445","author":"J Cunha-Santos","year":"2016","unstructured":"Cunha-Santos J, Duarte-Neves J, Carmona V, Guarente L, de Almeida LP, Cavadas C (2016) Caloric restriction blocks neuropathology and motor deficits in machado-joseph disease mouse models through SIRT1 pathway. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms11445","journal-title":"Nat Commun"},{"issue":"1","key":"4311_CR268","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MS9.0000000000001500","volume":"86","author":"N Thapar","year":"2024","unstructured":"Thapar N, Eid M, Raj N, Kantas T, Billing HS, Sadhu D (2024) Application of CRISPR\/cas9 in the management of Alzheimer\u2019s disease and Parkinson\u2019s disease: a review. Ann Med Surg (Lond) 86(1):329\u2013335. https:\/\/doi.org\/10.1097\/MS9.0000000000001500","journal-title":"Ann Med Surg (Lond)"},{"key":"4311_CR269","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065798","author":"B Kar","year":"2023","unstructured":"Kar B, Castillo SR, Sabharwal A, Clark KJ, Ekker SC (2023) Mitochondrial base editing: recent advances towards therapeutic opportunities. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065798","journal-title":"Int J Mol Sci"},{"key":"4311_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2015.12.003","author":"JC Chang","year":"2016","unstructured":"Chang JC, Wu SL, Liu KH et al (2016) Allogeneic\/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson\u2019s disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity. Transl Res. https:\/\/doi.org\/10.1016\/j.trsl.2015.12.003","journal-title":"Transl Res"},{"issue":"4","key":"4311_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00355","volume":"21","author":"H Eo","year":"2024","unstructured":"Eo H, Yu SH, Choi Y et al (2024) Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson\u2019s disease. Neurotherapeutics 21(4):e00355. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00355","journal-title":"Neurotherapeutics"},{"key":"4311_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2023.11.007","author":"R Jain","year":"2024","unstructured":"Jain R, Begum N, Rajan S, Tryphena KP, Khatri DK (2024) Role of f-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson\u2019s disease mouse model. Mitochondrion. https:\/\/doi.org\/10.1016\/j.mito.2023.11.007","journal-title":"Mitochondrion"},{"key":"4311_CR273","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12112006","author":"X Yang","year":"2023","unstructured":"Yang X, Zhou P, Zhao Z et al (2023) Improvement effect of mitotherapy on the cognitive ability of Alzheimer\u2019s disease through NAD (+)\/SIRT1-mediated autophagy. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox12112006","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"4311_CR274","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","volume":"34","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu H, Luo S et al (2017) Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online 34(4):361\u2013368. https:\/\/doi.org\/10.1016\/j.rbmo.2017.01.013","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"4311_CR275","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T, Yang Y, Qi H et al (2023) CRISPR\/cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 8(1):36. https:\/\/doi.org\/10.1038\/s41392-023-01309-7","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4311_CR276","doi-asserted-by":"publisher","first-page":"9438","DOI":"10.1038\/s41467-024-53806-0","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Liu Y, Ou L et al (2024) Transfer of mitochondrial DNA into the nuclear genome during induced DNA breaks. Nat Commun 15(1):9438. https:\/\/doi.org\/10.1038\/s41467-024-53806-0","journal-title":"Nat Commun"},{"key":"4311_CR277","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176365","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Ito M, Arai M, Hibino M, Tsujioka T, Harashima H (2020) Challenges in promoting mitochondrial transplantation therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176365","journal-title":"Int J Mol Sci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04311-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:11:44Z","timestamp":1738411904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04311-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":277,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4311"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04311-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"61"}}